National Peroxide Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	2,777	2,869	3,330
Revenue Growth (YoY)	-7.79%	-13.85%	-
Cost of Revenue	2,014	2,075	2,227
Gross Profit	762.95	793.78	1,103
Selling, General & Admin	257.81	304.41	292.75
Other Operating Expenses	365.61	337.27	434.45
Operating Expenses	829.36	842.76	919.8
Operating Income	-66.41	-48.98	183.32
Interest Expense	-14.16	-16.65	-19.82
Interest & Investment Income	6.64	6.64	5.14
Currency Exchange Gain (Loss)	4.05	4.05	6.03
Other Non Operating Income (Expenses)	11	9.92	12.9
EBT Excluding Unusual Items	-58.88	-45.03	187.57
Gain (Loss) on Sale of Investments	24.26	24.26	25.43
Gain (Loss) on Sale of Assets	-	-	2.13
Pretax Income	-40.44	-20.77	215.14
Income Tax Expense	-6.62	1.7	47.24
Net Income	-33.82	-22.46	167.9
Net Income to Common	-33.82	-22.46	167.9
Shares Outstanding (Basic)	6	6	6
Shares Outstanding (Diluted)	6	6	6
EPS (Basic)	-5.89	-3.91	29.22
EPS (Diluted)	-5.89	-3.91	29.22
Free Cash Flow	-	137.78	217.7
Free Cash Flow Per Share	-	23.97	37.88
Dividend Per Share	-	-	12.500
Gross Margin	27.47%	27.67%	33.13%
Operating Margin	-2.39%	-1.71%	5.50%
Profit Margin	-1.22%	-0.78%	5.04%
Free Cash Flow Margin	-	4.80%	6.54%
EBITDA	135.47	145.24	367.33
EBITDA Margin	4.88%	5.06%	11.03%
D&A For EBITDA	201.88	194.22	184.01
EBIT	-66.41	-48.98	183.32
EBIT Margin	-2.39%	-1.71%	5.50%
Effective Tax Rate	-	-	21.96%
Revenue as Reported	2,823	2,914	3,381

Source: S&P Capital IQ. Standard template. Financial Sources.